$2.68T
Total marketcap
$59.71B
Total volume
BTC 49.90%     ETH 17.10%
Dominance

Coloplast A/S COLO-B.CO Stock

822 DKK {{ price }} -2.421655% {{change_pct}}%
COUNTRY
Denmark
Exchange
Copenhagen
Market Cap
184.98B DKK
LOW - HIGH [24H]
822 - 838.8 DKK
VOLUME [24H]
285.67K DKK
{{ volume }}
P/E Ratio
36.68
Earnings per share
22.41 DKK

Coloplast A/S Price Chart

Coloplast A/S COLO-B.CO Financial and Trading Overview

Coloplast A/S stock price 822 DKK
Previous Close 849.2 DKK
Open 850.2 DKK
Bid 866.2 DKK x 0
Ask 867.2 DKK x 0
Day's Range 847 - 867.8 DKK
52 Week Range 737.8 - 993 DKK
Volume 44.16K DKK
Avg. Volume 219.27K DKK
Market Cap 181.42B DKK
Beta (5Y Monthly) 0.283908
PE Ratio (TTM) 37.859325
EPS (TTM) 22.41 DKK
Forward Dividend & Yield 20 (2.35%)
Ex-Dividend Date May 15, 2023
1y Target Est 955.06 DKK

COLO-B.CO Valuation Measures

Enterprise Value 200.87B DKK
Trailing P/E 37.859325
Forward P/E 30.611092
PEG Ratio (5 yr expected) 3.41
Price/Sales (ttm) 7.5359354
Price/Book (mrq) 26.169407
Enterprise Value/Revenue 8.344
Enterprise Value/EBITDA 25.846

Trading Information

Coloplast A/S Stock Price History

Beta (5Y Monthly) 0.283908
52-Week Change 12.44%
S&P500 52-Week Change 20.43%
52 Week High 993 DKK
52 Week Low 737.8 DKK
50-Day Moving Average 916.39 DKK
200-Day Moving Average 851.56 DKK

COLO-B.CO Share Statistics

Avg. Volume (3 month) 219.27K DKK
Avg. Daily Volume (10-Days) 254.79K DKK
Shares Outstanding 194.31M
Float 130.82M
Short Ratio N/A
% Held by Insiders 35.90%
% Held by Institutions 26.33%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 20
Trailing Annual Dividend Yield 2.35%
5 Year Average Dividend Yield 204.00%
Payout Ratio 0.885
Last Split Factor 5:1

Financial Highlights

Fiscal Year

Fiscal Year Ends September 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End September 30, 2023

Profitability

Profit Margin 19.94%
Operating Margin (ttm) 29.19%
Gross Margin 68.08%
EBITDA Margin 32.28%

Management Effectiveness

Return on Assets (ttm) 12.46%
Return on Equity (ttm) 67.11%

Income Statement

Revenue (ttm) 24.07B DKK
Revenue Per Share (ttm) 113.37 DKK
Quarterly Revenue Growth (yoy) 10.19%
Gross Profit (ttm) 15.53B DKK
EBITDA 7.77B DKK
Net Income Avi to Common (ttm) 4.8B DKK
Diluted EPS (ttm) 22.89
Quarterly Earnings Growth (yoy) 17.89%

Balance Sheet

Total Cash (mrq) 644M DKK
Total Cash Per Share (mrq) 3.03 DKK
Total Debt (mrq) 21.65B DKK
Total Debt/Equity (mrq) 307.76 DKK
Current Ratio (mrq) 0.988
Book Value Per Share (mrq) 33.115

Cash Flow Statement

Operating Cash Flow (ttm) 4.89B DKK
Levered Free Cash Flow (ttm) 3.36B DKK

Profile of Coloplast A/S

Country Denmark
State N/A
City Humlebæk
Address Holtedam 1-3
ZIP 3050
Phone 45 49 11 11 11
Website https://www.coloplast.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 14973

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Q&A For Coloplast A/S Stock

What is a current COLO-B.CO stock price?

Coloplast A/S COLO-B.CO stock price today per share is 822 DKK.

How to purchase Coloplast A/S stock?

You can buy COLO-B.CO shares on the Copenhagen exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Coloplast A/S?

The stock symbol or ticker of Coloplast A/S is COLO-B.CO.

Which industry does the Coloplast A/S company belong to?

The Coloplast A/S industry is Medical Instruments & Supplies.

How many shares does Coloplast A/S have in circulation?

The max supply of Coloplast A/S shares is 225.04M.

What is Coloplast A/S Price to Earnings Ratio (PE Ratio)?

Coloplast A/S PE Ratio is 36.68005400 now.

What was Coloplast A/S earnings per share over the trailing 12 months (TTM)?

Coloplast A/S EPS is 22.41 DKK over the trailing 12 months.

Which sector does the Coloplast A/S company belong to?

The Coloplast A/S sector is Healthcare.

Coloplast A/S COLO-B.CO included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
OMX Copenhagen Benchmark Cap_PI OMXCBCAPPI 1511.98 DKK 221.69 USD
-1.31
1511.98 DKK 221.69 USD 1525.84 DKK 223.72 USD
OMX Copenhagen 25 Index OMXC25 1972.85 DKK 289.26 USD
-0.57
1959.43 DKK 287.29 USD 1977.77 DKK 289.98 USD
OMX Copenhagen 20 OMXC20 2728.24 DKK 400.02 USD
-0.86
2720.72 DKK 398.92 USD 2744.93 DKK 402.46 USD
OMX_Nordic_Large_Cap_ISK_GI OMXNLCISKGI 634.66 ISK 4.67 USD
-1.38
633.35 ISK 4.66 USD 641.19 ISK 4.71 USD
Nasdaq Developed Select Leaders NQDMSLC 1260.81 USD
0
1243.71 USD 1264.94 USD
OMX_Nordic_Large_Cap_DKK_GI OMXNLCDKKGI 442.32 DKK 64.85 USD
-1.51
442.01 DKK 64.81 USD 447.45 DKK 65.61 USD
NASDAQ OMX Nordic 120 SEK Net I NOMXN120SEKNI 2662.02 SEK 259.85 USD
-0.93
2660.84 SEK 259.73 USD 2681.67 SEK 261.76 USD
OMX Copenhagen_PI OMXCPI 1913.82 DKK 280.61 USD
-0.89
1910.92 DKK 280.18 USD 1923.96 DKK 282.09 USD
NASDAQ OMX Nordic 120 Gross Ind NOMXN120GI 2589 EUR 2830.13 USD
-1.36
2585.12 EUR 2825.89 USD 2617.25 EUR 2861 USD
OMX Copenhagen_GI OMXCGI 3594.64 DKK 527.05 USD
-0.89
3589.18 DKK 526.25 USD 3613.67 DKK 529.84 USD
OMX Copenhagen Health Care PI CX20PI 9886.86 DKK 1449.62 USD
-0.67
9849 DKK 1444.07 USD 9919.82 DKK 1454.45 USD
OMX Copenhagen Cap_GI OMXCCAPGI 2877.16 DKK 421.85 USD
-1.27
2877.16 DKK 421.85 USD 2903.1 DKK 425.66 USD
OMX Copenhagen Benchmark_GI OMXCBGI 4404.61 DKK 645.81 USD
-0.86
4393.99 DKK 644.25 USD 4425.88 DKK 648.93 USD
OMX Copenhagen Benchmark Cap_GI OMXCBCAPGI 2774.73 DKK 406.83 USD
-1.31
2774.73 DKK 406.83 USD 2800.18 DKK 410.57 USD
OMX Copenhagen 20 CAP OMXC20CAP 1835.4 DKK 269.11 USD
<0.01
1835.4 DKK 269.11 USD 1835.4 DKK 269.11 USD
OMX_Nordic_Large_Cap_SEK_GI OMXNLCSEKGI 548.48 SEK 53.54 USD
-1.08
548.48 SEK 53.54 USD 552.59 SEK 53.94 USD
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1390.15 USD
<0.01
2100.38 AUD 1390.15 USD 2100.38 AUD 1390.15 USD
OMX_Nordic_Large_Cap_EUR_GI OMXNLCEURGI 442.13 EUR 483.31 USD
-1.51
441.8 EUR 482.95 USD 447.23 EUR 488.88 USD
NASDAQ OMX Nordic Health Care N NOMXNHCNI 5660.74 EUR 6187.96 USD
-1.14
5659.97 EUR 6187.11 USD 5712.33 EUR 6244.35 USD
OMX Nordic 40 OMXN40 2821.33 EUR 3084.09 USD
-1.33
2815.81 EUR 3078.06 USD 2850.26 EUR 3115.72 USD